You can access the original SEC filing by clicking here.
Ownership Summary Table
|Name||Sole Voting Power||Shared Voting Power||Sole Dispositive Power||Shared Dispositive Power||Aggregate Amount Owned Power||Percent of Class|
|Baker Bros. Advisors||5,032,313||0||5,032,313||0||5,032,313||15.2%|
|Baker Bros. Advisors (GP)||5,032,313||0||5,032,313||0||5,032,313||15.2%|
|Felix J. Baker||5,032,313||0||5,032,313||0||5,032,313||15.2%|
|Julian C. Baker||5,032,313||0||5,032,313||0||5,032,313||15.2%|
Page 1 of 10 – SEC Filing
WASHINGTON, DC 20549
Securities Exchange Act of 1934
(Amendment No. )*
Bellicum Pharmaceuticals, Inc.
(Name of Issuer)
Common Stock, par value $0.01 per share
(Title of Class of Securities)
(Date of Event which Requires Filing of
appropriate box to designate the rule pursuant to which this Schedule is filed:
* The remainder
of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject
class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior
required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18
of the Securities Exchange Act of 1934 (the “Act”) or otherwise subject to the liabilities of that section of the
Act, but shall be subject to all other provisions of the Act (however, see the Notes).